Food & Health

Nestlé Exceeds Q3 Sales Amid Russia Exit

Nestlé (NESN.S) reported third-quarter organic sales growth that topped analyst forecasts on Thursday, even as the Swiss food giant formally deconsolidated its Russian operations after Moscow seized control of the business. The Russia deconsolidation removes a persistent geopolitical...

Merck's $1.3B Move Spurs Biotech Shakeup

Germany’s Merck KGaA agreed Monday to acquire Nasdaq-listed Silence Therapeutics (SLN) for $1.3...

AI Revolution Fuels AstraZeneca's $1.5B Pharma Deal

AstraZeneca (AZN.L) sealed a deal worth up to $1.5 billion with AI therapeutics firm Insitro on Thursday, signaling that machine-learning platforms...

GSK's $800M Investment Fuels Biopharma Reshoring

AstraZeneca Invests $1B in MA R&D Expansion

FDA Approves Juvmo: Parkinson's Treatment Breakthrough

Lilly Inks $3.35B Deal with InnoCare for New Drug Paths

Enicepatide Boosts Roche in Cardio Drug Arena

Pfizer's $2B Vaccine Standoff Eyes Air-Traffic Fees

1 month ago

Pfizer (PFE) is pressing a roughly $2 billion arbitration claim against Poland and Romania over cancelled Covid-19 vaccine orders, an escalating legal fight that has now swept...

Smithfield Faces Pork Segment Loss Amid Margin Collapse

1 month ago

Smithfield Foods (SFD.O) shares fell nearly 2% in extended trading on Tuesday after the pork giant said its fresh pork segment will swing to an adjusted operating loss in Q3, a...

Novartis Faces Setbacks in Pipeline Tension

1 month ago

A neuromuscular drug candidate acquired through Novartis’s (NVS) $12 billion Avidity Biosciences deal missed its late-stage primary endpoint, compounding a difficult stretch...

Ionis Secures FDA Nod for First Alexander Therapy

1 month ago

Ionis Pharmaceuticals (IONS.O) secured the first FDA approval for Alexander disease on Thursday, with analysts projecting the injectable therapy could reach $295 million in peak...

Brazil infant formula investment illustration

Nestlé Invests Heavily in Brazil Infant Formula Sector

1 month ago

Nestlé (NESN.S) said Thursday it will commit 2 billion reais ($392.73 million) to its Brazilian nutrition and health division through 2028, anchored by a new infant formula factory...

Food & Health

Pfizer's $2B Vaccine Standoff Eyes Air-Traffic Fees

Smithfield Faces Pork Segment Loss Amid Margin Collapse

Novartis Faces Setbacks in Pipeline Tension

Ionis Secures FDA Nod for First Alexander Therapy

Nestlé Invests Heavily in Brazil Infant Formula Sector

MORE NEWS

Novartis Faces CAR-T Challenges in Autoimmune Trials

JBS Billionaire Spurs Shift in U.S. Beef Tariffs

J&J's Imaavy: A Breakthrough in Rare Blood Disorder

CATEGORIES